SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 76 filers reported holding SYNTA PHARMACEUTICALS CORP in Q4 2015. The put-call ratio across all filers is 1.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $1,002,000 | +1.6% | 3,851,153 | -6.3% | 0.00% | – |
| Q1 2016 | $986,000 | -34.7% | 4,111,858 | -4.1% | 0.00% | – |
| Q4 2015 | $1,509,000 | -74.5% | 4,286,483 | +26.0% | 0.00% | – |
| Q3 2015 | $5,918,000 | -12.9% | 3,400,795 | +11.6% | 0.00% | – |
| Q2 2015 | $6,796,000 | +24.5% | 3,047,509 | +8.3% | 0.00% | – |
| Q1 2015 | $5,459,000 | -2.1% | 2,813,918 | +33.7% | 0.00% | – |
| Q4 2014 | $5,576,000 | +6.9% | 2,104,570 | +21.4% | 0.00% | – |
| Q3 2014 | $5,216,000 | -17.4% | 1,732,936 | +12.3% | 0.00% | – |
| Q2 2014 | $6,313,000 | -5.4% | 1,543,451 | -0.3% | 0.00% | -100.0% |
| Q1 2014 | $6,676,000 | -10.9% | 1,548,801 | +8.3% | 0.00% | 0.0% |
| Q4 2013 | $7,491,000 | +8.9% | 1,429,649 | +31.2% | 0.00% | 0.0% |
| Q3 2013 | $6,877,000 | +30.9% | 1,089,947 | +3.5% | 0.00% | 0.0% |
| Q2 2013 | $5,253,000 | – | 1,052,728 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 21,704,847 | $5,209,000 | 7.19% |
| CAXTON CORP | 67,000 | $16,000 | 0.02% |
| McQueen, Ball & Associates Inc. | 102,742 | $25,000 | 0.02% |
| TWO SIGMA SECURITIES, LLC | 36,056 | $9,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,398,330 | $336,000 | 0.01% |
| WEDBUSH SECURITIES INC | 45,000 | $11,000 | 0.00% |
| Roundview Capital LLC | 21,100 | $5,000 | 0.00% |
| Renaissance Technologies | 2,332,995 | $560,000 | 0.00% |
| PANAGORA ASSET MANAGEMENT INC | 618,599 | $148,000 | 0.00% |
| Virtu KCG Holdings LLC | 107,071 | $26,000 | 0.00% |